NASDAQ
Finch Therapeutics Group, Inc. (FNCH) has a current ratio of 3.39x as of Monday, May 25, 2026. This represents a 54.82% decrease compared to its 12-month average of 7.51x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.